litlas
ログインアカウント作成

Andreas Neubauer

1987–2025 年に発表

150
論文数
21,225
被引用数
79
h 指数
138
i10 指数

被引用数

Andreas Neubauer の年別被引用数1979 年: 被引用 3 件1988 年: 被引用 3 件1990 年: 被引用 1 件1991 年: 被引用 7 件1992 年: 被引用 16 件1993 年: 被引用 12 件1994 年: 被引用 20 件1995 年: 被引用 18 件1996 年: 被引用 16 件1997 年: 被引用 21 件1998 年: 被引用 16 件1999 年: 被引用 27 件2000 年: 被引用 39 件2001 年: 被引用 54 件2002 年: 被引用 82 件2003 年: 被引用 102 件2004 年: 被引用 96 件2005 年: 被引用 151 件2006 年: 被引用 98 件2007 年: 被引用 134 件2008 年: 被引用 140 件2009 年: 被引用 122 件2010 年: 被引用 158 件2011 年: 被引用 131 件2012 年: 被引用 129 件2013 年: 被引用 127 件2014 年: 被引用 141 件2015 年: 被引用 126 件2016 年: 被引用 138 件2017 年: 被引用 154 件2018 年: 被引用 133 件2019 年: 被引用 503 件2020 年: 被引用 629 件2021 年: 被引用 667 件2022 年: 被引用 548 件2023 年: 被引用 470 件2024 年: 被引用 596 件2025 年: 被引用 240 件2026 年: 被引用 12 件1980〜1987 年は被引用が無いため表示していません1989 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,878 件、この内訳の 23.1%ドイツ: 引用元論文 983 件、この内訳の 12.1%イタリア: 引用元論文 516 件、この内訳の 6.4%イギリス: 引用元論文 506 件、この内訳の 6.2%中国: 引用元論文 493 件、この内訳の 6.1%フランス: 引用元論文 449 件、この内訳の 5.5%日本: 引用元論文 246 件、この内訳の 3%スペイン: 引用元論文 244 件、この内訳の 3%オランダ: 引用元論文 230 件、この内訳の 2.8%オーストラリア: 引用元論文 227 件、この内訳の 2.8%カナダ: 引用元論文 207 件、この内訳の 2.6%スイス: 引用元論文 202 件、この内訳の 2.5%
0%23.1%その他 23.9%

機関

分野

  • Medicine73.9%
  • Biochemistry, Genetics and Molecular Biology9.8%
  • Immunology and Microbiology6.3%
  • Mathematics4.4%
  • Engineering1.8%
  • Computer Science1.6%
  • その他2.2%

トピック

  • Acute Myeloid Leukemia Research11.8%
  • Chronic Myeloid Leukemia Treatments7.2%
  • Chronic Lymphocytic Leukemia Research4.4%
  • Hematopoietic Stem Cell Transplantation3.9%
  • Lymphoma Diagnosis and Treatment3.8%
  • Acute Lymphoblastic Leukemia research3.2%
  • その他65.7%

共著者

全論文

検索で開く
  1. Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3 -Mutated AML

    著者: Alexander E. Perl, Giovanni Martinelli, Jörge E. Cortes, Andreas Neubauer, Ellin Berman, Stefania Paolini, Pau Montesinos, Maria R. Baer, Richard A. Larson, Celalettin Üstün, Francesco Fabbiano, Harry P. Erba, Antonio Di Stasi, Robert K. Stuart, Rebecca L. Olin, Margaret Kasner, Fabio Ciceri, Wen‐Chien Chou, Nikolai A. Podoltsev, Christian Récher, Hisayuki Yokoyama, Naoko Hosono, Sung‐Soo Yoon, Je‐Hwan Lee, Timothy S. Pardee, Amir T. Fathi, Chaofeng Liu, Nahla Hasabou, Xuan Liu, Erkut Bahceci, Mark J. Levis - New England Journal of Medicine 2019 被引用: 1,239

  2. Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation (SORMAIN)

    著者: Andreas Burchert, Gesine Bug, Lea Fritz, Jürgen Finke, Matthias Stelljes, Christoph Röllig, Ellen Wollmer, Ralph Wäsch, Martin Bornhäuser, Tobias Berg, Fabian Lang, Gerhard Ehninger, Hubert Serve, Robert Zeiser, Eva-Maria Wagner, Nicolaus Kröger, Christine Wolschke, Michael Schleuning, Katharina S. Götze, Christoph Schmid, Martina Crysandt, Eva Eßeling, Dominik Wolf‎, Ying Wang, Alexandra Böhm, Christian Thiede, Torsten Haferlach, Christian Michel, Wolfgang Bethge, Thomas Wündisch, Christian Brandts, Susanne Harnisch, Michael Wittenberg, Heinz‐Gert Hoeffkes, Susanne Rospleszcz, Alexander Burchardt, Andreas Neubauer, Markus Brugger, Konstantin Strauch, Carmen Schade‐Brittinger, Stephan Metzelder - Journal of Clinical Oncology 2020 被引用: 551

  3. Iterative Regularization Methods for Nonlinear Ill-Posed Problems

    著者: Barbara Kaltenbacher, Andreas Neubauer, Otmar Scherzer - DAGLIB 2008 被引用: 796

  4. CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome

    著者: Franziska Taube, Julia Annabell Georgi, Michael Krämer, Sebastian Stasik, Jan Moritz Middeke, Christoph Röllig, Utz Krug, Alwin Krämer, Sebastian Scholl, Andreas Hochhaus, Tim H. Brümmendorf, Ralph Naumann, A. Petzold, Roger Mulet‐Lazaro, Peter J.M. Valk, Björn Steffen, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Kerstin Schäfer‐Eckart, Christoph Schliemann, Stefan W. Krause, Mathias Hänel, Richard Noppeney, Ulrich Kaiser, Claudia D. Baldus, Martin Kaufmann, Sylvia Herold, Friedrich Stölzel, Katja Sockel, Malte von Bonin, Carsten Müller‐Tidow, Uwe Platzbecker, Wolfgang E. Berdel, Hubert Serve, Gerhard Ehninger, Martin Bornhäuser, Johannes Schetelig, Christian Thiede, for the Study Alliance Leukemia (SAL) - Blood 2021 被引用: 164

  5. Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study

    著者: Alexander E. Perl, Jessica K. Altman, Jörge E. Cortes, Catherine C. Smith, Mark R. Litzow, Maria R. Baer, David F. Claxton, Harry P. Erba, Stan Gill, Stuart L. Goldberg, Joseph G. Jurcic, Richard A Larson, Chaofeng Liu, Ellen K. Ritchie, Gary J. Schiller, Alexander I. Spira, Stephen A. Strickland, Raoul Tibes, Celalettin Üstün, Eunice S. Wang, Robert K. Stuart, Christoph Röllig, Andreas Neubauer, Giovanni Martinelli, Erkut Bahceci, Mark J. Levis - The Lancet Oncology 2017 被引用: 488

  6. Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

    著者: for the SAKK and the German CML Study Group, Rüdiger Hehlmann, Michael Lauseker, Susanne Saußele, Markus Pfirrmann, Stefan W. Krause, Hans‐Jochem Kolb, Andreas Neubauer, Dieter K. Hossfeld, C. Nerl, Aloïs Gratwohl, Gabriela M. Baerlocher, Dominik Heim, Tim H. Brümmendorf, Alice Fabarius, Claudia Haferlach, Brigitte Schlegelberger, Marcus Müller, Sabine Jeromin, Ulrike Proetel, Katharina Kohlbrenner, Astghik Voskanyan, Sébastien Rinaldetti, Wolfgang Seifarth, Birgit Spieß, Leopold Balleisen, M-E Goebeler, Mathias Hänel, Anthony D. Ho, Jolanta Dengler, Christiane Falge, Lothar Kanz, Stephan Kremers, Andreas Burchert, Michael Kneba, Frank Stegelmann, Claus-Henning Köhne, H. W. Lindemann, Cornelius F. Waller, M. Pfreundschuh, Karsten Spiekermann, Wolfgang E. Berdel, Lothar Müller, Matthias Edinger, Jiřı́ Mayer, Dietrich W. Beelen, Martin Bentz, Hartmut Link, Bernd Hertenstein, Roland J. Fuchs, Martin Wernli, Frank Schlegel, Rudolf Schlag, Maike de Wit, Lorenz Trümper, Holger Hebart, Markus Hahn, Jörg Thomalla, Christof Scheid, Philippe Schafhausen, Walter Verbeek, Michael J. Eckart, W. Gaßmann, Antonio Pezzutto, Michael Schenk, Peter Brossart, Thomas Geer, Stephan Bildat, E. Schäfer, Andreas Hochhaus, Joerg Hasford - Leukemia 2017 被引用: 339

  7. Follow-up of patients with R/R FLT3-mutation–positive AML treated with gilteritinib in the phase 3 ADMIRAL trial

    著者: Alexander E. Perl, Richard A. Larson, Nikolai A. Podoltsev, Stephen A. Strickland, Eunice S. Wang, Ehab Atallah, Gary J. Schiller, Giovanni Martinelli, Andreas Neubauer, Jorge Sierra, Pau Montesinos, Christian Récher, Sung‐Soo Yoon, Naoko Hosono, Masahiro Onozawa, Shigeru Chiba, Hee‐Je Kim, Nahla Hasabou, Qiaoyang Lu, Ramón V. Tiu, Mark J. Levis - Blood 2022 被引用: 137

  8. Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

    著者: Robert Zeiser, Andreas Burchert, Claudia Lengerke, Mareike Verbeek, Kristina Maas‐Bauer, Stephan Metzelder, Silvia Spoerl, Markus Ditschkowski, Matyas Ecsedi, Katja Sockel, Francis Ayuk, Salem Ajib, Flore Sicre de Fontbrune, Il‐Kang Na, Livius Penter, Udo Holtick, Dominik Wolf‎, Esther Schuler, Everett Meyer, Petya Apostolova, Hartmut Bertz, Reinhard Marks, Michael Lübbert, Ralph Wäsch, Christof Scheid, Friedrich Stölzel, Rainer Ordemann, Gesine Bug, Guido Kobbe, Robert S. Negrin, Mats Brune, Alexandros Spyridonidis, A Schmitt-Gräff, Walter J. F. M. van der Velden, Gerwin Huls, Stephan Mielke, Goetz Ulrich Grigoleit, Jürgen Kuball, Ryan Flynn, Gabriele Ihorst, Jing Du, Bruce R. Blazar, R. Arnold, Nicolaus Kröger, Jakob Passweg, Jörg Halter, G. Socié, Dietrich W. Beelen, Christian Peschel, Andreas Neubauer, Jürgen Finke, Justus Duyster, Nikolas von Bubnoff - Leukemia 2015 被引用: 540

  9. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

    著者: Christian Thiede, Christine Steudel, Brigitte Mohr, Markus Schaich, Ulrike Schäkel, Uwe Platzbecker, Martin Wermke, Martin Bornhäuser, Markus Ritter, Andreas Neubauer, Gerhard Ehninger, Thomas Illmer - Blood 2002 被引用: 1,729

  10. Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial

    著者: Christoph Röllig, Hubert Serve, Andreas Hüttmann, Richard Noppeney, Carsten Müller‐Tidow, Utz Krug, Claudia D. Baldus, Christian Brandts, Volker Kunzmann, Hermann Einsele, Alwin Krämer, Kerstin Schäfer‐Eckart, Andreas Neubauer, Andreas Burchert, Aristoteles Giagounidis, Stefan W. Krause, Andréas Mackensen, Walter E. Aulitzky, Regina Herbst, Mathias Hänel, Alexander Kiani, Norbert Frickhofen, Johannes Kullmer, Ulrich Kaiser, Hartmut Link, Thomas Geer, A. Reichle, Christian Junghanß, Roland Repp, Frank Heits, Heinz Dürk, Jana Hase, Ina‐Maria Klut, Thomas Illmer, Martin Bornhäuser, Markus Schaich, Stefani Parmentier, Martin Görner, Christian Thiede, Malte von Bonin, Johannes Schetelig, Michael Krämer, Wolfgang E. Berdel, Gerhard Ehninger - The Lancet Oncology 2015 被引用: 400

  11. Ambulatory assessment for physical activity research: State of the science, best practices and future directions

    著者: Markus Reichert, Marco Giurgiu, Elena D. Koch, Lena M. Wieland, Sven Lautenbach, Andreas Neubauer, Birte von Haaren‐Mack, René Schilling, Irina Timm, Nanna Notthoff, Isabel Marzi, Holger Hill, Sarah Brüßler, Tobias Eckert, Janis Fiedler, Alexander Burchartz, Bastian Anedda, Kathrin Wunsch, Markus Gerber, Darko Jekauc, Alexander Wöll, Genevieve F. Dunton, Martina Kanning, Claudio R. Nigg, Ulrich Ebner‐Priemer, Yue Liao - Psychology of sport and exercise 2020 被引用: 178

  12. Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial

    著者: Viola Poeschel, Gerhard Held, Marita Ziepert, Mathias Witzens‐Harig, Harald Holte, Lorenz Thurner, Peter Borchmann, Andreas Viardot, Martin Soekler, Ulrich Keller, Christian Schmidt, Lorenz Truemper, Rolf Mahlberg, Reinhard Marks, Heinz‐Gert Hoeffkes, Bernd Metzner, Judith Dierlamm, Norbert Frickhofen, Mathias Haenel, Andreas Neubauer, Michael Kneba, Francesco Merli, Alessandra Tucci, Peter de Nully Brown, Massimo Federico, Eva Lengfelder, Alice Di Rocco, Ralf Ulrich Trappe, Andreas Rosenwald, Christian Berdel, Martin Maisenhoelder, Ofer Shpilberg, Josif Amam, Konstantinos Christofyllakis, Frank Hartmann, Niels Murawski, Stephan Stilgenbauer, Maike Nickelsen, Gerald Wulf, Bertram Glaß, Norbert Schmitz, Bettina Altmann, Markus Loeffler, Michael Pfreundschuh - The Lancet 2019 被引用: 253

  13. Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial

    著者: Maria‐Luisa Schubert, Anita Schmitt, Angela Hückelhoven‐Krauss, Brigitte Neuber, Alexander Kunz, Philip Waldhoff, Dominik Vonficht, Schayan Yousefian, Lea Jopp‐Saile, Lei Wang, Felix Korell, Anna Keib, Birgit Michels, Dominik Haas, Tim Sauer, Patrick Derigs, Andreas E. Kulozik, Joachim B. Kunz, Petra Pavel, Sascha Laier, Patrick Wuchter, Johann W. Schmier, Gesine Bug, Fabian Lang, Nicola Gökbuget, Jochen Casper, Martin Görner, Jürgen Finke, Andreas Neubauer, Mark Ringhoffer, Denise Wolleschak, Monika Brüggemann, Simon Haas, Anthony D. Ho, Carsten Müller‐Tidow, Peter Dreger, Michael Schmitt - Journal of Hematology & Oncology 2023 被引用: 36

  14. Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?

    著者: Christoph Röllig, Michael Krämer, Christoph Schliemann, Jan‐Henrik Mikesch, Björn Steffen, Alwin Krämer, Richard Noppeney, Kerstin Schäfer‐Eckart, Stefan W. Krause, Mathias Hänel, Regina Herbst, Volker Kunzmann, Hermann Einsele, Edgar Jost, Tim H. Brümmendorf, Sebastian Scholl, Andreas Hochhaus, Andreas Neubauer, Kristina Sohlbach, Lars Fransecky, Martin Kaufmann, Dirk Niemann, Markus Schaich, Norbert Frickhofen, Alexander Kiani, Frank Heits, Ulrich Krümpelmann, Ulrich Kaiser, Johannes Kullmer, Maxi Wass, Friedrich Stölzel, Malte von Bonin, Jan Moritz Middeke, Christian Thiede, Johannes Schetelig, Wolfgang E. Berdel, Gerhard Ehninger, Claudia D. Baldus, Carsten Müller‐Tidow, Uwe Platzbecker, Hubert Serve, Martin Bornhäuser - Blood 2020 被引用: 135

  15. 10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial

    著者: Michael Lübbert, Pierre W. Wijermans, Michal Kiciński, Sylvain Chantepie, Walter J. F. M. van der Velden, Richard Noppeney, Laimonas Griškevičius, Andreas Neubauer, Martina Crysandt, Radovan Vrḫovac, Mario Luppi, Stephan Fuhrmann, Ernesta Audisio, Anna Candoni, Olivier Legrand, Robin Foà, Gianluca Gaïdano, Daniëlle van Lammeren‐Venema, Eduardus F. M. Posthuma, Mels Hoogendoorn, Anne Giraut, Marian Stevens‐Kroef, Joop H. Jansen, Aniek O. de Graaf, Fabio Efficace, Emanuele Ammatuna, Jean‐Pierre Vilque, Ralph Wäsch, Heiko Becker, Nicole M. A. Blijlevens, Ulrich Dührsen, Frédéric Baron, Stefan Suciu, Sergio Amadori, Adriano Venditti, Gerwin Huls, Jürgen Finke, Nicolaas Petrus Michael Schaap, Andrius Zucenka, Stephan Metzelder, Edgar Jost, Zinaida Perić, Fabio Forghieri, Bernadino Allione, Maurizio Martelli, Anna Paola Iori, Sebastian Wittnebel, Andrea Mengarelli, Annalisa Imovilli, Attilio Olivieri, Bernard José Marie De Prijck, Marjolein W.M. van der Poel, Christian Junghanß, Helmut Rainer Salih, Agostino Tafuri, José Eduardo Guimarães, Maurizio Musso, Paolo De Fabritiis, Patrice Chevallier, Dominik Luc Selleslag, Nicola Cascavilla, Zwi Berneman, Aurélie Jaspers, Eliana Zuffa, Gaëtan Vanstraelen, Giuseppe Visani, Maria Louisa Henriëtte Cuijpers, Ann De Becker, Anna Maria Mianulli, Björn Hackanson, Georgi Georgiev Mihaylov, Giovanni Martinelli, Stefania Paolini, Pier Luigi Zinzani, Martin Henkes, Haifa Kathrin Al-Ali, Paul La Rosée, Anna Chierichini, Laura Cudillo, Giorgina Specchia, Njetočka Gredelj Šimec, Silvana Franca Capalbo, Giuseppina Spinosa, Stefano Molica, Susan Dorothé de Jonge-Peeters - The Lancet Haematology 2023 被引用: 37

  16. Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification

    著者: Jan‐Niklas Eckardt, Marius Bill, Christian Rausch, Klaus H. Metzeler, Karsten Spiekermann, Sebastian Stasik, Tim Sauer, Sebastian Scholl, Andreas Hochhaus, Martina Crysandt, Tim H. Brümmendorf, Utz Krug, Bernhard Wörmann, Wolfgang Hiddemann, Dennis Görlich, Cristina Sauerland, Björn Steffen, Hermann Einsele, Andreas Neubauer, Andreas Burchert, Kerstin Schäfer‐Eckart, Wolfgang E. Berdel, Christoph Schliemann, Stefan W. Krause, Mathias Hänel, Maher Hanoun, Martin Kaufmann, Lars Fransecky, Jan Braess, Leo Ruhnke, Johannes Schetelig, Jan Moritz Middeke, Hubert Serve, Claudia D. Baldus, Uwe Platzbecker, Carsten Müller‐Tidow, Martin Bornhäuser, Tobias Herold, Christian Thiede, Christoph Röllig - Leukemia 2023 被引用: 36

  17. Mutation-based, short-term “neoadjuvant” treatment allows resectability in stage IVB and C anaplastic thyroid cancer

    著者: Elisabeth Maurer, Friederike Eilsberger, Sabine Wächter, Jorge Riera Knorrenschild, Anika Pehl, Katharina Holzer, Andreas Neubauer, Markus Luster, Detlef K. Bartsch - European Archives of Oto-Rhino-Laryngology 2023 被引用: 33

  18. Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial

    著者: Martin Bornhäuser, Joachim Kienast, Rudolf Trenschel, Andreas Burchert, Ute Hegenbart, Michael Stadler, H. Baurmann, Kerstin Schäfer‐Eckart, Ernst Holler, Nicolaus Kröger, Christoph Schmid, H. Einsele, Michael Kiehl, Wolfgang Hiddemann, Rainer Schwerdtfeger, Stefanie Buchholz, Peter Dreger, Andreas Neubauer, Wolfgang E. Berdel, Gerhard Ehninger, Dietrich W. Beelen, Johannes Schetelig, Matthias Stelljes - The Lancet Oncology 2012 被引用: 272

  19. axl , a Transforming Gene Isolated from Primary Human Myeloid Leukemia Cells, Encodes a Novel Receptor Tyrosine Kinase

    著者: John P. O’Bryan, Roy A. Frye, Patricia C. Cogswell, Andreas Neubauer, Barry Kitch, Carol Prokop, Rafael Espinosa, Michelle M. Le Beau, H. Shelton Earp, Edison T. Liu - Molecular and Cellular Biology 1991 被引用: 230

  20. High-risk additional chromosomal abnormalities at low blast counts herald death by CML

    著者: Rüdiger Hehlmann, Astghik Voskanyan, Michael Lauseker, Markus Pfirrmann, Lida Kalmanti, Sébastien Rinaldetti, Katharina Kohlbrenner, Claudia Haferlach, Brigitte Schlegelberger, Alice Fabarius, Wolfgang Seifarth, Birgit Spieß, Patrick Wuchter, Stefan W. Krause, Hans‐Jochem Kolb, Andreas Neubauer, Dieter K. Hossfeld, Christoph Nerl, Aloïs Gratwohl, Gabriela M. Baerlocher, Andreas Burchert, Tim H. Brümmendorf, Jörg Hasford, Andreas Hochhaus, Susanne Saußele, Michele Baccarani, for the SAKK and the German CML Study Group, Ludwig Fischer von Weikersthal, Markus Hahn, Günter Schlimok, Dietmar Reichert, Jan Janßen, Uwe M. Martens, Peter Majunke, Peter Reichert, Kai Neben, Stefan Korsten, Ch. Scholz, Bernd Oldenkott, Jörg Heßling, D. Kingreen, Christian Sperling, C. Schelenz, I. W. Blau, A. Urmersbach, W. D. Ludwig, Philipp le Coutre, R. Arnold, Maike de Wit, Antonio Pezzutto, E. Schäfer, Roland Schroers, A. Lochter, Dirk Behringer, Y. Ko, St. Weidenhöfer, Walter Verbeek, Peter Brossart, Guido Trenn, W Pommerien, J. Krauter, G. Döering, H. Munzinger, C. Diekmann, Bernd Hertenstein, Sebastian Stier, F. Möller-Faßbender, Mathias Hänel, T. Zöller, C. Lamberti, Babette Koch, A. Henzel, Siegfried Wagner, A. Schmalenbach, M. Hoffknecht, Gerhard Ehninger, Alexander Kiani, Thomas Illmer, Carlo Aul, Michael Flaßhove, F. Henneke, M. Simon, Lothar Müller, Heiko Becker, R. F. Janz, Michael J. Eckart, Roland J. Fuchs, Frank Schlegel, Mohammad Amen Wattad, R. Rudolph, Dietrich W. Beelen, A Lindemann, D. Linck, Wassman, Elke Jäger, Salah‐Eddin Al‐Batran, T Reiber, Cornelius F. Waller, Heinz‐Gert Hoeffkes, L.S. Schulz ほか 154 名 - Leukemia 2020 被引用: 92

  21. Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations

    著者: Jan‐Niklas Eckardt, Friedrich Stölzel, Desireé Kunadt, Christoph Röllig, Sebastian Stasik, Lisa Wagenführ, Korinna Jöhrens, Friederike Kuithan, Alwin Krämer, Sebastian Scholl, Andreas Hochhaus, Martina Crysandt, Tim H. Brümmendorf, Ralph Naumann, Björn Steffen, Volker Kunzmann, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Kerstin Schäfer‐Eckart, Christoph Schliemann, Stefan W. Krause, Regina Herbst, Mathias Hänel, Maher Hanoun, Ulrich Kaiser, Martin Kaufmann, Zdeněk Ráčil, Jiřı́ Mayer, Frank Kroschinsky, Wolfgang E. Berdel, Gerhard Ehninger, Hubert Serve, Carsten Müller‐Tidow, Uwe Platzbecker, Claudia D. Baldus, Johannes Schetelig, Martin Bornhäuser, Christian Thiede, Jan Moritz Middeke - Journal of Hematology & Oncology 2022 被引用: 59

  22. Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage Chemotherapy

    著者: Alexander E. Perl, Richard A. Larson, Nikolai A. Podoltsev, Stephen A. Strickland, Eunice S. Wang, Ehab Atallah, Gary J. Schiller, Giovanni Martinelli, Andreas Neubauer, Jorge Sierra, Pau Montesinos, Christian Récher, Sung‐Soo Yoon, Yoshinobu Maeda, Naoko Hosono, Masahiro Onozawa, Takayasu Kato, Hee‐Je Kim, Nahla Hasabou, Rishita Nuthethi, Ramón V. Tiu, Mark J. Levis - Transplantation and Cellular Therapy 2022 被引用: 39

  23. Autoantibodies are highly prevalent in non–SARS-CoV-2 respiratory infections and critical illness

    著者: Allan Feng, Emily Yang, A. R. Moore, Shaurya Dhingra, Sarah E. Chang, Xihui Yin, Ruoxi Pi, Elisabeth Mack, Sara Völkel, Reinhard Geßner, Margrit Gündisch, Andreas Neubauer, Harald Renz, Sotirios Tsiodras, Paraskevi C. Fragkou, Adijat Asuni, Joseph E. Levitt, Jennifer G. Wilson, Michelle Leong, Jennifer H. Lumb, Rong Mao, Kassandra Pinedo, Jonasel Roque, Christopher M. Richards, Mikayla A. Stabile, Gayathri Swaminathan, Maria Salagianni, Vasiliki Triantafyllia, Wilhelm Bertrams, Catherine A. Blish, Jan E. Carette, Jennifer Frankovich, Eric Meffre, Kari C. Nadeau, Upinder Singh, Taia T. Wang, Eline T. Luning Prak, Susanne Herold, Evangelos Andreakos, Bernd Schmeck, Chrysanthi Skevaki, Angela J. Rogers, Paul J. Utz - JCI Insight 2023 被引用: 28

  24. Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV

    著者: Lida Kalmanti, Susanne Saußele, Michael Lauseker, M. C. Muller, Christian Dietz, Linda Heinrich, Benjamin Hanfstein, Ulrike Proetel, Alice Fabarius, Stefan W. Krause, Sébastien Rinaldetti, Jolanta Dengler, Christiane Falge, Elisabeth Oppliger Leibundgut, Andreas Burchert, Andreas Neubauer, Lothar Kanz, Frank Stegelmann, Michael Pfreundschuh, Karsten Spiekermann, Christof Scheid, Markus Pfirrmann, Andreas Hochhaus, Joerg Hasford, R. Hehlmann, for the SAKK and the German CML Study-Group - Leukemia 2015 被引用: 274